Você procurou por: becaplermin (Inglês - Eslovaco)

becaplermin
bekaplermin

regranex becaplermin
regranex bekaplermín

regranex 0.01% gel becaplermin
regranex 0,01% gél bekaplermín

100 microgram / g gel becaplermin
100 mikrogramov bekaplermínu / g gélu

it contains a substance called becaplermin.
obsahuje látku nazývanú bekaplermín.

each gram of gel contains 100 g of becaplermin
jeden gram gélu obsahuje 100 g bekaplermínu.

the active substance in regranex is becaplermin.
liečivo v regranex je bekaplermín.

regranex contains100 µg of becaplermin per gram of gel.
regranex obsahuje 100 μg bekaplermínu na gram gélu.

each gram of regranex contains 100 micrograms of becaplermin.
jeden gram regranexu obsahuje 100 mikrogramov bekaplermínu.

regranex is a gel that contains the active substance becaplermin.
liek regranex je gél, ktorý obsahuje účinnú látku bekaplermín.

it is not known whether becaplermin is excreted in human milk.
nie je známe, či sa bekaplermín vylučuje do materského mlieka.

in the process of healing the wound, becaplermin induces cell proliferation.
v procese hojenia rany bekaplermín indukuje proliferáciu buniek.

becaplermin was not mutagenic in a battery of in vitro and in vivo tests.
bekaplermín nebol mutagénny v sérii testov in vitro a in vivo.

becaplermin is a human recombinant platelet derived growth factor (rhpdgf).
bekaplermín je rekombinantný ľudský doštičkový rastový faktor (rhpdgf).

the biological activity of becaplermin includes promoting the chemotactic recruitment and proliferation of cells involved in wound repair.
biologická aktivita bekaplermínu zahŕňa podporu chemotaxie a proliferácie buniek zúčastňujúcich sa na hojení rán.

malignancies distant from the site of application have occurred in becaplermin users in both clinical trial and in post-marketing use.
v klinickej štúdii i počas postmarketingového používania sa u používateľov bekaplermínu objavili malígne ochorenia vzdialené od miesta aplikácie.

becaplermin is produced by insertion of the gene for the b chain of human platelet derived growth factor into the yeast, saccharomyces cerevisiae.
bekaplermín sa získava inzerciou génu reťazca b ľudského doštičkového rastového faktora do kvasinky saccharomyces cerevisiae.

the active ingredient of regranex, becaplermin, is produced by a method known as ‘ recombinant dna technology’.
„ technológiou rekombinácie dna “.

regranex is a clear colourless to straw-coloured gel, which contains 0.01% of the active substance becaplermin.
regranex je číry bezfarebný až slamovožltý gél, ktorý obsahuje 0, 01% účinnej látky bekaplermínu.

regranex contains becaplermin, a recombinant human platelet derived growth factor-bb (rhpdgf-bb).
regranex obsahuje bekaplermín, rekombinantný ľudský doštičkový rastový faktor-bb (rhpdgf- bb).